BAP1 tumour predisposition syndrome (BAP1 TPS) is now recognised as an autosomal dominant condition where individuals carrying heterozygous BAP1 mutations are at high risk of mesothelioma and other cancers including melanoma [20]. This evidence concerns the gene BAP1 and cancer.